December 12, 2017

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment MMJ International Holding’s, the premier medical cannabis research company that is advancing the science […]
November 27, 2017

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and the operation of medical […]
November 13, 2017

MMJ BioScience Proceeding with FDA Multiple Sclerosis Clinical Trial of Medicinal Cannabis 2018

The MMJ BioScience team will be carefully conducting these controlled clinical studies to determine the benefits and risks of medical marijuana products for safe patient use. […]